| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +30.1K | 100% | $1.66 | +$50K |
| Sells | 0 | ||||
| Net | +2 | +30.1K | 100% | +$50K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| DeLyle W. Bloomquist | Resigned as a Director on June 17, 2021. | $7.81M | Jun 16, 2021 | ||
| Frank Bedu | President/CEO, Director | $6.76M | Jan 5, 2023 | ||
| Seth Van Voorhees | Chief Financial Officer | $173K | Jun 15, 2021 | ||
| Stephen C. Glover | Director | $131K | +$25K | +23.6% | Feb 28, 2025 |
| Gregory Gene Freitag | Director | $102K | +$25K | +32.6% | Feb 28, 2025 |
| Otis W. Brawley | Director | Jun 24, 2024 | |||
| Gregory Conn | Chief Scientific Officer | Jan 5, 2023 | |||
| Spencer D. Brown | Senior VP, General Counsel | Jan 5, 2023 | |||
| Ilian Iliev | Director | Jun 24, 2024 | |||
| Lauren Wood | Chief Medical Officer | Jan 5, 2023 | |||
| Richard Sykes | Director | Jun 24, 2024 | |||
| Stephan Toutain | Chief Operations Officer | May 1, 2024 | |||
| Janetta Trochimiuk | Principal Accounting Officer | Sep 30, 2021 | |||
| Lars Boesgaard | Chief Financial Officer | Dec 4, 2023 | |||
| Kirk V. Shepard | Chief Medical Officer | Jan 22, 2024 | |||
| Kamil Ali-Jackson | Director | Jun 24, 2024 | |||
| Matthew C. Hill | Chief Financial Officer | Jan 5, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|